Skip to main content
. 1999 Oct;73(10):8268–8278. doi: 10.1128/jvi.73.10.8268-8278.1999

TABLE 2.

Mutated residues in vIL-6

Position(s) Residue(s) Change(s) Mutant designation Activity Comments Reference(s)
13 G W 1 +++ Conserved
41, 43 W, L F, G 19 +++ Site II, gp130 interactions (hIL-6) 50, 52
54 C D 2 +++ Conserved
G 3 +++
60 C S 4 +++ Conserved
L 5 +++
75 P S 7 +++ Conserved
83 C G 8 +++ Conserved, functional (hIL-6) 46, 57
88 F L 20 +++ Site I, important for IL-6R binding (hIL-6) 59
93 C G 9 +++ Site I, conserved, functional (hIL-6) 46, 57
W 10 +++
103–105 EFE EGG 22 +++ Site I, E-103 conserved, important for IL-6R binding (hIL-6) 59
GVA 23 +++
129 T L 11 +++ Site II, conserved
A 12 +++
151 P F 13 +++ Conserved
S 14 +++
167 W G 15 + Site III, conserved
R 16 +++
167, 172 W, A R, P 24 + Site III, required for hexameric (functional) complex formation 13
183 F W 17 +++ Conserved, F to A in hIL-6 shows reduced cell surface binding 31
G 18 +++
E 29 +++
L 31 +++
189 R L S C 25 26 27 +++ +++ +++ Site I, conserved, positively charged residue at this position in hIL-6 important for binding and activity 20, 31
195 P Stop 28 +++ C-tail deletion, 195–204
HHS Vulnerability Disclosure